Author： Cortés Felipe Pastor Nuria Mateos Santiago Domínguez Inmaculada
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.5, 2007-05, pp. : 521-532
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Toxicity of the topoisomerase II inhibitors
By Seiter Karen
Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. :
Toxicity of the topoisomerase I inhibitors
By Seiter Karen
Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. :
Emerging DNA topoisomerase inhibitors as anticancer drugs
Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. :